Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | CDC25A | P30304 | 1/20 | 0.38 |
| ▸ | CDC25B | P30305 | 1/20 | 0.38 |
| ▸ | CDC25C | P30307 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6711266 | 0.95 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9ACHETDP1 | |
| SCHEMBL6711632 | 0.95 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9ACHETDP1 | |
| SCHEMBL19712281 | 0.95 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9ACHETDP1 | |
| Silver SCHEMBL10840126 | 0.95 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9ACHETDP1 | |
| SCHEMBL64752 | 0.95 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9ACHETDP1 | |
| Lithium Ion SCHEMBL411846 | 0.95 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9ACHETDP1 | |
| SCHEMBL3155238 | 0.95 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9ACHETDP1 | |
| Zinc Ion SCHEMBL1863861 | 0.95 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9ACHETDP1 | |
| SCHEMBL1022294 | 0.95 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9ACHETDP1 | |
| Water SCHEMBL941226 | 0.92 | ALDH1A1 (0.46) | ALDH1A1CYP3A4CYP2C9ACHETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 396 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1199303-B1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL CO (JP) | 2004-09-22 | — | — | EP | claimed |
| US-20040034257-A1 | Novel sulfone derivatives and process for producing these | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-02-19 | — | — | US | claimed |
| US-6660888-B2 | A disulfone compound of given formula | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-12-09 | — | — | US | claimed |
| EP-1359143-A1 | NOVEL SULFONE DERIVATIVES AND PROCESS FOR PRODUCING THESE | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2003-11-05 | — | — | EP | claimed |
| EP-1199303-A1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-24 | — | — | EP | claimed |
| US-5621084-A | Process for removal of allyl group or allyloxycarbonyl group | PFIZER INC. (US) | 1997-04-15 | — | — | US | claimed |
| EP-0676236-A1 | Process for removal of allyl group or allyloxycarbonyl group | PFIZER INC. (US) | 1995-10-11 | — | — | EP | claimed |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | KURARAY NORITAKE DENTAL INC. (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4717249-A1 | DENTAL COMPOSITION | Shofu Inc. (JP) | 2026-04-01 | — | — | EP | disclosed |
| US-20260083642-A1 | DENTAL COMPOSITION | SHOFU INC (JP) | 2026-03-26 | — | — | US | disclosed |
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | SHOFU INC. (JP) | 2026-03-05 | — | — | US | disclosed |
| US-12478562-B2 | Dental restoration material composition | KURARAY NORITAKE DENTAL INC. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-12465559-B2 | Fluorescent curable dental composition and cured product thereof | KURARAY NORITAKE DENTAL INC. (JP) | 2025-11-11 | — | — | US | disclosed |
| EP-0676236-A1 | Process for removal of allyl group or allyloxycarbonyl group | PFIZER INC. (US) | 1995-10-11 | — | — | EP | disclosed |
| US-4740596-A | Process for preparation of 4-sulfonylthio azetidinone derivatives | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1988-04-26 | — | — | US | disclosed |
| US-4713452-A | Process for preparation of azetidinone derivatives | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1987-12-15 | — | — | US | disclosed |
| US-4257915-A | USE IN PHOTOPOLYMERIZATION OF ETHYLENICALLY UNSATURATED MONOMERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-03-24 | — | — | US | disclosed |
| US-4211676-A | Process for reclaiming scrap vulcanized rubber | BRIDGESTONE TIRE COMPANY LIMITED (JP) | 1980-07-08 | — | — | US | disclosed |
| US-4039334-A | ORGANIC SILVER SALT AND HALIDE, REDUCING AGENT, ROSIN | FUJI PHOTO FILM CO., LTD. (JA) | 1977-08-02 | — | — | US | disclosed |
| US-3988328-A | PLANT GROWTH REGULATORS, HERBICIDES | SANDOZ LTD. (CH) | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | BOLA2; BOLA2B, LBR, COL2A1 | ALDH1A1 314/4885CYP3A4 4813/4885CYP2C9 4569/4885 |
| US-12465559-B2 | Fluorescent curable dental composition and cured product thereof | BRD1, TBCA, BAZ1A | ALDH1A1 1780/4885CYP3A4 3149/4885CYP2C9 2952/4885 |
| US-20040034257-A1 | Novel sulfone derivatives and process for producing these | RBP4, ADH4, RARB | ALDH1A1 323/4885CYP3A4 123/4885CYP2C9 163/4885 |
| US-12478562-B2 | Dental restoration material composition | CAD, MAT2B, RER1 | ALDH1A1 209/4885CYP3A4 2289/4885CYP2C9 1482/4885 |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | MSL1, ITGA1, ITGAL | ALDH1A1 668/4885CYP3A4 2922/4885CYP2C9 1741/4885 |
| US-20260083642-A1 | DENTAL COMPOSITION | TAS2R42, COL2A1, TAS2R1 | ALDH1A1 1319/4885CYP3A4 4710/4885CYP2C9 3641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.